Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Diabetes Group Pushes Broader Use Of HbA1c Test For Disease Diagnosis

This article was originally published in The Gray Sheet

Executive Summary

The American Diabetes Association is seeking broader support from government agencies for use of the hemoglobin A1c (HbA1c) test as a screening and diagnostic tool for Type 2 diabetes

You may also be interested in...

New Products In Brief

Bausch & Lomb gets approval for first-of-a-kind intraocular lens. Roche HbA1c assay is first to be cleared to diagnose diabetes. More product launches and approvals from the past week.

FDA letter to HbA1c test makers

FDA is encouraging makers of hemoglobin A1c (HbA1c) assays to meet with the agency if they wish to pursue new diagnostic claims for their blood tests based on new data and updated guidance from the American Diabetes Association. ADA recently updated its recommendations for diabetes treatment standards to state that HbA1c test values of greater than or equal to 6.5% may be used to diagnose diabetes. However, no HbA1c test has yet been cleared by FDA with a diagnosis claim. The tests are cleared to monitor long-term glucose control in diabetes patients

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts